These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15598795)

  • 1. No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women.
    Travis RC; Churchman M; Edwards SA; Smith G; Verkasalo PK; Wolf CR; Wolf H; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2282-4. PubMed ID: 15598795
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
    Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
    Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
    Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
    Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
    Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):737-44. PubMed ID: 19672705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
    Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
    Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of polymorphism of genetic markers of CYP19 and CYP17 with sporadic breast cancer].
    Artamonov VV; Liubchenko LN; Shabanov MA; Babenko OV; Nemtsova MV; Zaletaev DV
    Mol Biol (Mosk); 2003; 37(6):975-82. PubMed ID: 14714492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.
    Somner J; McLellan S; Cheung J; Mak YT; Frost ML; Knapp KM; Wierzbicki AS; Wheeler M; Fogelman I; Ralston SH; Hampson GN
    J Clin Endocrinol Metab; 2004 Jan; 89(1):344-51. PubMed ID: 14715870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
    Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
    Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between estrogen-biosynthesis gene (CYP17, CYP19, HSD17beta1) polymorphisms and breast cancer].
    Wang YP; Li H; Li JY; Yuan P; Yang F; Lei FM; Pang Y; Guo J
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):899-903. PubMed ID: 20193327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphism and variability of steroid hormone metabolism: connection with risk of developing breast neoplasms].
    Kristensen VN; Harada N; Kristensen T; Borresen-Dale AL
    Vopr Onkol; 2001; 47(2):156-9. PubMed ID: 11383450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
    Sobczuk A; Romanowicz H; Fiks T; Połać I; Smolarz B
    Pol J Pathol; 2009; 60(4):163-7. PubMed ID: 20072949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.
    Iwasaki M; Hamada GS; Nishimoto IN; Netto MM; Motola J; Laginha FM; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Kobayashi M; Ishihara J; Yamamoto S; Hanaoka T; Tsugane S
    Nutr Cancer; 2010; 62(4):466-75. PubMed ID: 20432167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
    Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP17 (T34C), CYP19 (Trp39Arg), and FGFR2 (C906T) polymorphisms and the risk of breast cancer in south Indian women.
    Samson M; Rama R; Swaminathan R; Sridevi V; Nancy KN; Rajkumar T
    Asian Pac J Cancer Prev; 2009; 10(1):111-4. PubMed ID: 19469636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis.
    Szczepańska M; Wirstlein P; Skrzypczak J; Jagodziński PP
    Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1188-93. PubMed ID: 23809139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.
    Ahsan H; Whittemore AS; Chen Y; Senie RT; Hamilton SP; Wang Q; Gurvich I; Santella RM
    Breast Cancer Res; 2005; 7(1):R71-81. PubMed ID: 15642171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
    Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
    Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
    Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility and environmental estrogen-like compounds.
    Kristensen VN; Kure EH; Erikstein B; Harada N; Børresen-Dale A
    Mutat Res; 2001 Oct; 482(1-2):77-82. PubMed ID: 11535251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.